Effect of Heating Human Sera at a Temperature Necessary to Deactivate Human Immunodeficiency Virus on Measurement of Free Phenytoin, Free Valproic Acid, and Free Carbamazepine Concentrations
- 1 August 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 21 (4) , 421-425
- https://doi.org/10.1097/00007691-199908000-00007
Abstract
Minimizing the risk for infection to laboratory staff from a contaminated blood sample is a major safety goal in the clinical laboratory. One dangerous pathogen, the human immunodeficiency virus (HIV), can be deactivated by heating sera at 56°C for 30 minutes. The authors previously reported that if serum was subjected to those conditions, the concentrations of the nine most commonly monitored drugs were not altered, whereas phenytoin and carbamazepine concentrations were reduced slightly. Monitoring free phenytoin, free valproic acid, and free carbamazepine concentrations is strongly recommended for patients with uremia, liver disease, and hypoalbuminemia. Because drug protein binding can be affected by temperature, the authors investigated the effect on free drug concentrations of sera heated to levels necessary for deactivation of the HIV virus. They measured total and free drug concentrations in serum pools prepared from patients receiving phenytoin, valproic acid, and carbamazepine. Serum pools were heated at 56°C for 30 minutes and then brought to room temperature. The total and free drug concentrations were measured immediately after heating and then at 20- and 45-minute intervals. The concentrations of free phenytoin and free valproic acid were significantly higher after heat treatment. However, after equilibration of sera at room temperature for 20 minutes, the free concentrations of phenytoin were comparable to preheating values, although total phenytoin concentrations (Serum Separator Tubes) were reduced slightly. In contrast, free valproic acid concentrations did not return to the original levels even after 45 minutes. Free carbamazepine concentrations did not change even immediately after heating. However, total carbamazepine concentrations were reduced slightly when sera were heated in serum separator tubes (SST Tubes).Keywords
This publication has 7 references indexed in Scilit:
- Heat Treatment of Human Serum to Inactivate HIV Does Not Alter Protein Binding of Selected DrugsTherapeutic Drug Monitoring, 1997
- Elevated Free Fatty Acid Concentrations in Lipemic Sera Reduce Protein Binding of Valproic Acid Significantly More Than PhenytoinThe Lancet Healthy Longevity, 1997
- Stability of Therapeutic Drug Measurement in Specimens Collected in VACUTAINER Plastic Blood-Collection TubesTherapeutic Drug Monitoring, 1996
- Absorption of Therapeutic Drugs by Barrier Gels in Serum Separator Blood Collection Tubes:Volume- and Time-dependent Reduction in Total and Free Drug ConcentrationsaAmerican Journal of Clinical Pathology, 1994
- Drug protein binding in chronic renal failure: Evaluation of nine drugsKidney International, 1988
- INACTIVATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS BY HEAT, GAMMA RAYS, AND ULTRAVIOLET LIGHTThe Lancet, 1985
- Drug Protein Binding and the Nephrotic SyndromeClinical Pharmacokinetics, 1976